Sulzberger–Garbe syndrome
| Sulzberger–Garbe syndrome | |
|---|---|
| Synonyms | Prurigo nodularis |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Itching, nodules on the skin |
| Complications | Infection due to scratching |
| Onset | Adulthood |
| Duration | Chronic |
| Types | N/A |
| Causes | Unknown, possibly related to atopic dermatitis or lichen simplex chronicus |
| Risks | Atopy, eczema, allergic rhinitis |
| Diagnosis | Clinical diagnosis, skin biopsy |
| Differential diagnosis | Lichen planus, dermatitis herpetiformis, cutaneous lymphoma |
| Prevention | N/A |
| Treatment | Topical corticosteroids, antihistamines, phototherapy |
| Medication | N/A |
| Prognosis | Variable, often chronic |
| Frequency | Rare |
| Deaths | N/A |
Stellwag's sign is a medical condition characterized by infrequent and incomplete blinking. It is named after the Austrian ophthalmologist, Carl Stellwag von Carion (1823–1904), who first described the condition. This sign is often associated with thyroid eye disease (TED), also known as Graves' ophthalmopathy.
Symptoms[edit]
The primary symptom of Stellwag's sign is a reduced rate of blinking. This can lead to dryness and discomfort in the eyes. In severe cases, it can cause damage to the cornea, the clear front surface of the eye.
Causes[edit]
Stellwag's sign is most commonly associated with thyroid eye disease. This is a condition in which the immune system attacks the muscles and other tissues around the eyes. It is most common in people with Graves' disease, a type of hyperthyroidism.
Diagnosis[edit]
Diagnosis of Stellwag's sign is typically made through a clinical examination. The doctor may observe the patient's blinking rate and ask about any symptoms of eye discomfort. Further tests may be needed to diagnose the underlying cause of the condition.
Treatment[edit]
Treatment for Stellwag's sign focuses on managing the underlying cause of the condition. This may involve medication to control thyroid hormone levels in cases of thyroid eye disease. Artificial tears or other treatments may be used to manage symptoms of dryness and discomfort in the eyes.
See also[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
